Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to -$703000.0.

  • Vanda Pharmaceuticals' Other Working Capital Changes fell 11919.72% to -$703000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 34333.08%. This contributed to the annual value of $6.8 million for FY2024, which is 17997.18% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Other Working Capital Changes of -$703000.0 as of Q3 2025, which was down 11919.72% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Other Working Capital Changes registered a high of $13.4 million during Q1 2022, and its lowest value of -$11.3 million during Q1 2023.
  • In the last 5 years, Vanda Pharmaceuticals' Other Working Capital Changes had a median value of $1.3 million in 2024 and averaged $621000.0.
  • Examining YoY changes over the last 5 years, Vanda Pharmaceuticals' Other Working Capital Changes showed a top increase of 2682000.0% in 2022 and a maximum decrease of 39811.32% in 2022.
  • Vanda Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$1.7 million in 2021, then crashed by 104.57% to -$3.4 million in 2022, then crashed by 108.59% to -$7.2 million in 2023, then skyrocketed by 150.58% to $3.6 million in 2024, then tumbled by 119.33% to -$703000.0 in 2025.
  • Its Other Working Capital Changes stands at -$703000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $5.4 million for Q1 2025.